VI
Vivanza Biosciences Limited
VIVANZA.BO · BSE
₹1.89 +0.53% (+₹0.01)
1M -0.53%
Market Cap ₹75.2M
P/E Ratio 16.56x
Div. Yield -
ROE 10.12%
Bulios Fair Price
₹2.44
29.1% upside
Trenutna cena
₹1.89
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica VIVANZA.BO trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
71 /100
Cheap EV/EBITDA 14.44x
P/S 0.06x
P/B 1.73x
Growth
51 /100
Stable Rev. growth 86.71%
Book val. growth 2.13%
EPS growth 12.64%
Profitability
4 /100
Weak Net margin 0.39%
Op. margin 0.41%
FCF margin 0.00%
Quality
46 /100
Average ROE 10.12%
ROA N/A
Asset turnover N/A
Debt
81 /100
Low Int. coverage 1.61x
Net debt/EBITDA 0.00x
Debt/Equity 0.00x
Stability
6 /100
Unstable Rev. volatility 851.15%
EPS volatility 188.72%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VIVANZA.BO
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Jayendra Mehta
Employees
6
Headquarters
Ahmedabad